| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Michael Gnant | |
| P2860 | cites work | Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy | Q46417627 |
| In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients | Q46610436 | ||
| Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer | Q49237337 | ||
| Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study | Q73132141 | ||
| Reduction in new metastases in breast cancer with adjuvant clodronate treatment | Q74837359 | ||
| The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer | Q24597847 | ||
| Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026] | Q28195767 | ||
| Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials | Q29547513 | ||
| Metastasis to bone: causes, consequences and therapeutic opportunities | Q29614310 | ||
| Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial | Q30416847 | ||
| Osteoporosis due to cancer treatment: pathogenesis and management | Q33874458 | ||
| Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole | Q34783300 | ||
| Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer | Q34813227 | ||
| Endocrine therapy plus zoledronic acid in premenopausal breast cancer. | Q34943802 | ||
| American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. | Q35951294 | ||
| Bone mineral density changes during the menopause transition in a multiethnic cohort of women | Q36494395 | ||
| Meta-analysis of clodronate and breast cancer survival | Q36609657 | ||
| Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer | Q37121724 | ||
| Exploring the anti-tumour activity of bisphosphonates in early breast cancer. | Q37142755 | ||
| The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance | Q37152481 | ||
| Bisphosphonates in the prevention of disease recurrence: current results and ongoing trials. | Q37660427 | ||
| Randomized, open label, prospective study on the effect of zoledronic acid on the prevention of bone metastases in patients with recurrent solid tumors that did not present with bone metastases at baseline | Q39365611 | ||
| A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer | Q39621014 | ||
| Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients | Q42475572 | ||
| Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer | Q45007476 | ||
| Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients | Q45151602 | ||
| Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group | Q46167555 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 298-304 | |
| P577 | publication date | 2010-10-29 | |
| P1433 | published in | Breast Care | Q15764648 |
| P1476 | title | Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients | |
| P478 | volume | 5 |
| Q35095533 | Osteooncology - Specific Aspects in Breast Cancer Patients | cites work | P2860 |
Search more.